GSK Triumphs In Avodart Patent Challenge
GlaxoSmithKline LLC scored a win Friday when a Delaware federal judge upheld its patent for the prostate reduction pill Avodart, saying Banner Pharmacaps Inc., Mylan Pharmaceuticals Inc. and other generic-drug makers...To view the full article, register now.
Already a subscriber? Click here to view full article